Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -.--% | -.--% | -99.76% |
Apr. 26 | Motion for Asset Sale Approved for Biocept, Inc. | CI |
Apr. 02 | Motion for Asset Sale Approved for Biocept, Inc. | CI |
Quotes 5-day view
Delayed Quote OTC Markets2024-05-31 | |
---|---|
Last | 0.0001 $ |
Volume | 2 460 |
Change | +∞% |
Opening | 0.00 |
High | 0.00 |
Low | 0.00 |
Performance
3 months | -99.92% | ||
6 months | -99.80% | ||
Current year | -99.76% | ||
1 year | -100.00% | ||
3 years | -100.00% | ||
5 years | -100.00% | ||
10 years | -100.00% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Diagnostic & Testing Substances
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
-.--% | -.--% | -99.76% | -100.00% | 262 | ||
-0.90% | -3.45% | -6.76% | +1.87% | 11.98B | ||
-0.59% | -2.59% | -5.68% | +31.13% | 8B | ||
+0.84% | +2.64% | +8.91% | +4.76% | 5.85B | ||
-2.16% | -2.36% | +28.87% | -10.00% | 5.54B | ||
-3.75% | -6.45% | -15.84% | -11.52% | 3.84B | ||
-1.30% | -0.48% | +10.70% | +4.83% | 2.66B | ||
-2.93% | -2.45% | -60.92% | -59.74% | 2.62B | ||
-1.36% | -1.95% | -6.99% | -16.85% | 2.33B | ||
-0.72% | -2.72% | +15.67% | -4.82% | 2B | ||
-1.08% | -1.40% | -8.85% | -4.25% | 1.78B | ||
-1.29% | -9.18% | -6.39% | +6.27% | 1.45B | ||
+0.58% | +0.46% | -9.37% | -24.25% | 1.4B | ||
+0.86% | -5.72% | -24.67% | +8.34% | 1.27B | ||
-2.11% | -2.72% | -17.46% | -21.20% | 1.1B | ||
+0.24% | -4.07% | -17.51% | +0.84% | 1.07B | ||
Average | -0.98% | -2.01% | -13.50% | -12.16% | ||
Weighted average by Cap. | -1.07% | -2.51% | -3.75% | -0.70% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | -99.76% | ||
2023 | -99.74% | ||
2022 | -85.36% | ||
2021 | -18.47% | ||
2020 | +55.24% | ||
2019 | -66.75% | ||
2018 | -95.87% | ||
2017 | -10.46% | ||
2016 | -81.28% | ||
2015 | -44.35% | ||
2014 | -73.62% |
- Stock Market
- Equities
- BIOC.Q Stock
- Quotes Biocept, Inc.